Analysis
Effective Canadian policy to reduce harms from prescription opioids: learning from past failures
Benedikt Fischer, Jürgen Rehm and Mark Tyndall
CMAJ December 06, 2016 188 (17-18) 1240-1244; DOI: https://doi.org/10.1503/cmaj.160356
Benedikt Fischer
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (Fischer, Rehm); Department of Psychiatry (Fischer, Rehm), University of Toronto; Institute of Medical Science, Faculty of Medicine (Fischer, Rehm), University of Toronto; Dalla Lana School of Public Health (Rehm), University of Toronto, Toronto, Ont.; Department of Medicine (Tyndall), Faculty of Medicine, The University of British Columbia; BC Centre for Disease Control (Tyndall), Vancouver, BC
PhDJürgen Rehm
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (Fischer, Rehm); Department of Psychiatry (Fischer, Rehm), University of Toronto; Institute of Medical Science, Faculty of Medicine (Fischer, Rehm), University of Toronto; Dalla Lana School of Public Health (Rehm), University of Toronto, Toronto, Ont.; Department of Medicine (Tyndall), Faculty of Medicine, The University of British Columbia; BC Centre for Disease Control (Tyndall), Vancouver, BC
PhDMark Tyndall
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (Fischer, Rehm); Department of Psychiatry (Fischer, Rehm), University of Toronto; Institute of Medical Science, Faculty of Medicine (Fischer, Rehm), University of Toronto; Dalla Lana School of Public Health (Rehm), University of Toronto, Toronto, Ont.; Department of Medicine (Tyndall), Faculty of Medicine, The University of British Columbia; BC Centre for Disease Control (Tyndall), Vancouver, BC
MD ScDData supplements
Earn CPD Credits
This article is eligible for 0.5 Mainpro credits.
Did you read this article?Note: The YES link above may not work in certain versions of Internet Explorer 8. If you are having difficulties with this link, please try another browser.
Related Articles
- Socías, M. E., & Ahamad, K. (2016). An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders. CMAJ, 188(17-18), 1208-1209. Accessed April 20, 2024. https://doi.org/10.1503/cmaj.160554.
- (2016). Highlights. CMAJ, 188(17-18), 1202. Accessed April 20, 2024. Retrieved from http://www.cmaj.ca/content/188/17-18/1202.
In this issue
Article tools
Respond to this article
Effective Canadian policy to reduce harms from prescription opioids: learning from past failures
Benedikt Fischer, Jürgen Rehm, Mark Tyndall
CMAJ Dec 2016, 188 (17-18) 1240-1244; DOI: 10.1503/cmaj.160356
Jump to section
Related Articles
Cited By...
- New opioid prescription claims and their clinical indications: results from health administrative data in Quebec, Canada, over 14 years
- Systematic assessment of opioid advertisements in general medical journals
- Cohort profile: development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada
- Effect of preoperative long-term opioid therapy on patient outcomes after total knee arthroplasty: an analysis of multicentre population-based administrative data
- Opioid deaths in Ontario, Canada
- Guideline for opioid therapy and chronic noncancer pain
- An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders